Inhibition of TNF alpha decrease amyloid plaques and tau phosphorylation in the mouse brain, and so risk of AD (44), and this protein involved in the pathophysiology of NAFLD (45). This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.